
Fidson trades just 12 shares and the silence is loud
Fidson’s near-empty order book says what its earnings cannot.
Page 2 of 15.

Fidson’s near-empty order book says what its earnings cannot.

NGX Invest now accepts public offer subscriptions via WhatsApp.

Ionis stands to earn up to $400M after Roche’s kidney drug clears Phase 3.

CBN rate reset brings the MPR back to life.

Chipper Cash locks in a deal no African fintech has matched

Meta added two checkout partners in a week; Amazon blocked it out

One policy shift could trigger a Medicare insurance shakeout

Airtel Money’s $213 billion fintech empire is heading to London

CBN cuts rate to 23% in a reset the market had already priced in

An unmapped cable corridor keeps draining MTN’s network ambitions

A sweeping draft law may let third parties tap M-PESA data

Novo’s CagriSema beat a low dose of Lilly’s tirzepatide on 21 September, but investors sold on 2030 ambitions that pitch the drugmaker as an ordinary-growth pharma

The Dangote IPO is fully digital and closes on October 13.

Dangote’s next chapter rests on three daughters and a 2030 target

Deutsche Bank, Société Générale, Santander and four members of a euro stablecoin consortium joined the ECB’s central bank settlement rail on its first day

The Nigerian IPO comes first, but Chairman Aliko Dangote is looking towards something bigger.

Up to $1 billion in passive capital is now eyeing NGX stocks

Five estimates value a Dangote Refinery share between ₦176 and ₦697.

Bamboo and Cowrywise are waiving every fee on the Dangote IPO because the customer is worth more than the transaction.

Otedola spent decades building wealth through oil and power, but a banking giant now accounts for most of his billionaire fortune.

Medtronic’s robotic platform now has its vessel-sealing tool in the US, but the procedures it can actually perform there haven’t changed yet.

Buffett completed a 61-year transition that puts the trillion-dollar conglomerate fully into the hands of its next generation.

AI agent payment rails are multiplying fast, but screened data shows actual agent-driven commerce is still barely a trickle.

Roughly 4.5 million people still carry a medigap plan that stopped accepting new buyers six years ago, and the exit keeps getting smaller.

Aradel Holdings captured nearly a fifth of all trade value on the Nigerian Exchange as oil stocks powered a fifth consecutive day of gains.

AI stocks rallied after the Fed hiked rates, but not everyone is buying the bounce.

J&J sold its $400 million Laminar program, narrowing competition for Boston Scientific and Abbott in LAA closure.

Warren Buffett’s crisis-era rule about greed and fear is trending again as Treasury yields spike and investor confidence slides fast.

Nine Chowdeck riders shared what they actually take home after the CEO’s viral pay claim.

Stablecoin card spending hit $4.5B in 2025, but the real constraint on new programs is daily settlement funding, not deman
Newsletter
One email every Sunday. The week’s most useful guides, market-moving stories, and practical tools — chosen by our editors.